CASSIE FLOYD: Open Payments
NPI 1720594161 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,133 in 139 payments from 17 companies in 2025. Trend: 2023 $1,093 · 2024 $1,656 · 2025 $2,133
Food & beverage: $2,133
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $476 |
| Janssen Biotech, Inc. | 27 | $445 |
| Ardelyx, Inc. | 15 | $252 |
| Lilly USA, LLC | 13 | $209 |
| Madrigal Pharmaceuticals | 7 | $134 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 13 | $81 |
| Novo Nordisk Inc | 3 | $51 |
Products named: TREMFYA, IBSRELA, RINVOQ, OMVOH, REZDIFFRA, DUPIXENT, CREON, ZENPEP.
Industry payments across SC — which companies pay providers there.
